Anebulo Pharmaceuticals I... (ANEB)

AI Score

Unlock

1.02

-0.02 (-1.92%)

At close: Apr 17, 2025, 3:59 PM

1.01

-1.46%

After-hours: Apr 17, 2025, 04:05 PM EDT

Anebulo Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Net Income	-2.46M	-2.2M	-1.35M	-1.65M	-2.72M	-2.48M	-2.5M	-2.8M	-3.83M	-2.61M	-2.32M	-1.88M	-1.07M	-1.55M	-29.11M	-555.83K	-328.6K	-256.38K
Depreciation & Amortization	59.7K	59.7K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	564.33K	286.92K	177.19K	151.64	219.26	210.80	223.57	223.64K	225.62	211.9K	226.95K	125.25K	94.28K	34.17K	115.44K	47.41K	20.69K	16.41K
Other Working Capital	-408.51K	68.41K	-711.36K	-121.41K	899.83K	-31.4K	-540.87K	159.44K	919.9K	472.30	-201.02K	249.64K	230.83K	357.55K	-763.01K	-702.69K	-24.22K	-65.42K
Other Non-Cash Items	597.39K	n/a	59.7K	145.09K	31.84K	179.39K	259.92K	n/a	153.61K	-106.28	-70.6K	84.92K	545.16K	-349.6K	26.63M	-8.07K	4.03K	4.03K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-164.13K	164.13K	-939.85K	-55.17K	652.56K	-456.8K	-577.23K	383.79K	991.91K	366.01K	96.53K	289.97K	-220.04K	741.32K	-734.99K	-705.14K	-106.14K	100.98K
Operating Cash Flow	-1.41M	-1.69M	-2.05M	-1.5M	-1.81M	-2.73M	-2.85M	-2.19M	-2.61M	-2.03M	-2M	-1.46M	-1.2M	-777.9K	-3.1M	-1.22M	-410.02K	-134.96K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-8.21M	n/a	n/a	n/a
Other Financial Acitivies	15M	n/a	n/a	n/a	-62.35K	n/a	-68.16K	n/a	-248.93K	52.4K	n/a	n/a	n/a	n/a	19.78M	1.66M	n/a	n/a
Financial Cash Flow	15M	n/a	n/a	n/a	-62.35K	n/a	-68.16K	n/a	-248.93K	6.7M	n/a	n/a	n/a	n/a	19.78M	1.66K	n/a	n/a
Net Cash Flow	13.59M	-1.69M	-2.05M	-1.5M	-1.88M	-2.73M	-2.92M	-2.19M	-2.86M	4.67M	-2M	-1.46M	-1.2M	-777.9K	16.68M	827.08K	-410.02K	-134.96K
Free Cash Flow	-1.41M	-1.69M	-2.05M	-1.5M	-1.81M	-2.73M	-2.85M	-2.19M	-2.61M	-2.03M	-2M	-1.46M	-1.2M	-777.9K	-3.1M	-1.22M	-410.02K	-134.96K